Autolus Therapeutics PLC (NASDAQ:AUTL)

2.15
Delayed Data
As of Sep 30
 -0.08 / -3.59%
Today’s Change
1.96
Today|||52-Week Range
7.90
-58.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Revenue and IncomeNet Revenues0.000.000.00----
Depreciation And Amortization476.2K1.0M1.7M--
 
 
 
 
 
Operating ExpensesGross Income-476.2K-1.0M-1.7M--
 
 
 
 
General Expenses15.1M24.2M57.4M--
 
 
 
 
Research And Development10.4M16.1M36.3M--
 
 
 
 
Total Operating Expenses15.5M25.3M59.1M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.5M-25.3M-59.1M--
 
 
 
 
Other Expenses1.2M1.7M5.4M--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.3M-23.5M-52.2M--
 
 
 
 
Income Taxes-1.8M-3.7M-7.3M--
 
 
 
 
Net Income-12.5M-19.8M-44.9M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.1M40.1M31.6M--
 
 
 
 
Shares To Calculate EPS Diluted40.1M40.1M31.6M--
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.49-$1.42--
 
 
 
 
EPS Diluted-$0.31-$0.49-$1.42--